Parallax Volatility Advisers, L.P. Iovance Biotherapeutics, Inc. Put Options Transaction History

Parallax Volatility Advisers, L.P.

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$7.59 - $17.47 $17,457 - $40,181	2,300 New	2,300 $34,000
Q2 2021 Aug 16, 2021	SELL	$16.33 - $33.07 $3,265 - $6,614	-200 Reduced 16.67%	1,000 $26,000
Q1 2021 May 14, 2021	BUY	$28.67 - $52.59 $2,867 - $5,259	100 Added 9.09%	1,200 $37,000
Q4 2020 Feb 16, 2021	BUY	$28.04 - $50.26 $30,844 - $55,286	1,100 New	1,100 $51,000
Q4 2020 Feb 16, 2021	SELL	$28.04 - $50.26 $33,648 - $60,312	-1,200 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$27.75 - $36.3 $8,325 - $10,890	-300 Reduced 20.0%	1,200 $40,000
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $40,815 - $61,500	1,500 New	1,500 $40,000

312

237M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.18B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.